World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000024324
Date of registration: 07/10/2016
Prospective Registration: Yes
Primary sponsor: University of Miyazaki
Public title: Comparative study of routine MRI sequences for the diagnosis of cerebral venous sinus thrombosis
Scientific title: Comparative study of routine MRI sequences for the diagnosis of cerebral venous sinus thrombosis - The routine MRI for CVST
Date of first enrolment: 2016/10/07
Target sample size: 480
Recruitment status: Complete: follow-up complete
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028003
Study type:  Observational
Study design:  Not selected Not selected  
Phase:  Phase IV
Countries of recruitment
Japan
Contacts
Name: Toshinori    HIRAI
Address:  5200 Kihara, Kiyotake, Miyazaki Japan
Telephone: 0985852807
Email: toshinorh@med.miyazaki-u.ac.jp
Affiliation:  University of Miyazaki Department of Radiology, Faculty of Medicine
Name: Toshinori    HIRAI
Address:  5200 Kihara, Kiyotake, Miyazaki 889-1692 Japan
Telephone: 0985852807
Email: toshinorh@med.miyazaki-u.ac.jp
Affiliation:  University of Miyazaki Department of Radiology, Faculty of Medicine
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: 1.Patients with bleeding, edema or infarction involves brain hernia 2.Brain trauma (involve post operation) patient 3.Patient who have only cortical vein thrombosis or deep vein thrombosis. 4.Any others judged ineligible as a subject by the investigator

Age minimum: 20years-old
Age maximum: Not applicable
Gender: Male and Female
Health Condition(s) or Problem(s) studied
Cerebral venous sinus thrombosis
Intervention(s)
Primary Outcome(s)
Diagnostic performance of CVT by specific MRI findings: Sensitivity and Specificity of optimal MRI findings
Secondary Outcome(s)
Diagnostic performance of combination of MRI findings: Detection rate, Odds ratio, 95 % CI
Secondary ID(s)
Source(s) of Monetary Support
Bayer Yakuhin, Ltd
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date: 08/08/2018
Contact:
toshinorh@med.miyazaki-u.ac.jp
University of Miyazaki
+81985852807
toshinorh@med.miyazaki-u.ac.jp
Results
Results available: Yes
Date Posted:
Date Completed: 30/09/2019
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history